CHEMICALS · NSE/BSE: EXCELINDUS

Excel Industries Limited Earnings Summary — Q1 FY2027

Sentiment: Neutral
AI-generated summary
Generated 2026-08-21
Generated using: Official Earnings Press Release
Business Intelligence Report

Excel Industries Reports Revenue and Profit Contraction in Q1 FY2027 Amidst Margin Pressures

Quarterly Business Intelligence

Q1 FY2027
Financials from Financial Intelligence · data as of 2026-06-30
Revenue
₹294 Cr
QoQ +4.5%YoY -5.1%
Net Profit
₹29 Cr
QoQ +140.0%YoY -12.7%
Operating Profit
₹42 Cr
QoQ +92.9%YoY +0.5%
Operating Margin
14.4%
QoQ +661 bpsYoY +79 bps

AI Quarterly Scorecard™

64
/ 100
Healthy
Revenue Momentum61
Profit Growth75
Margin Expansion51
Growth Consistency72
Operating Efficiency66
Financial Stability59

Computed deterministically from the last 10 reported quarters.

Quarterly Business Momentum

Revenue & Growth
  • Revenue has increased for 3 consecutive quarters.
  • Revenue of ₹294 Cr is 5.1% lower year-on-year.
  • Revenue has compounded at 10.7% annualised over the last 10 quarters.
Profitability
  • Net profit of ₹29 Cr is 12.7% below the same quarter last year.
  • Profit growth is trailing revenue growth this quarter.
  • Net profit has compounded at 93.5% annualised across the period.
Margins
  • Operating margin stands at 14.4% in Q1 FY2027.
  • Operating margin expanded by 79 bps year-on-year.
  • Over the last two years operating margin has contracted by 12 bps.
  • PBT margin is 13.2%.
Operating Efficiency
  • Expense growth of -5.9% remained below revenue growth of -5.1%.
  • Operating profit of ₹42 Cr is 0.5% higher year-on-year.
  • Operating leverage continues to improve.
Overall Momentum
  • 5 of the last 6 measured quarters delivered year-on-year revenue growth.
  • Overall quarterly business momentum scores 64/100 (Healthy) on the latest 10 quarters.
  • Business momentum has softened and warrants monitoring.

Quarterly Financials

Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %

MetricTrend
Latest
Q1 FY2027
Q4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024
Revenue
Improving
294
281234270310248196269265234
Expenses
Stable
251
259218240267228184220226221
Operating Profit
Improving
42
221630422012493912
Operating Margin
Volatile
14.4%
7.8%6.7%11.1%13.6%7.9%6.2%18.2%14.6%5.2%
Other Income
Volatile
7
35712658115
Interest
Volatile
1
001100110
Depreciation
Stable
10
1099999988
Profit Before Tax
Improving
39
1511274416847419
Tax
Improving
9
236114211102
Net Profit
Improving
29
128213412636317
Net Margin
Volatile
10.0%
4.4%3.6%7.8%10.9%5.0%3.2%13.3%11.7%2.9%
Source: Financial Intelligence (Structured Quarterly Data)Latest Quarter: Q1 FY2027Figures in ₹ Crore • Margins in %Automatically updated from Financial Intelligence · 2026-06-30

Key Takeaways

  • Revenue for Q1 FY2027 declined 5.09% YoY to ₹293.73 Cr, though it showed a marginal 4.48% sequential improvement.
  • Net profit witnessed a 13.27% YoY contraction, settling at ₹29.11 Cr compared to ₹33.56 Cr in the year-ago period.
  • Operating margins recovered significantly on a quarter-on-quarter basis from 4.43% to 11.02%, largely due to a decrease in other expenses and inventory adjustments.
  • The Chemicals segment remains the sole reportable business segment, contributing the entirety of the operational revenue.
  • Total comprehensive income was bolstered significantly by changes in the fair value of equity instruments, amounting to ₹38.30 Cr for the quarter.
  • The company maintains a strong balance sheet position with a massive investment portfolio providing a valuation floor despite core operational volatility.

Management Guidance

Management maintains a long-term focus on niche chemical segments and phosphonates where they hold global leadership, though they note the current environment is impacted by cyclicality in the global chemical downturn.

Sentiment Shift

Stable

While YoY metrics show a decline, the sharp sequential (QoQ) recovery in margins and profitability suggests the company may be stabilizing from the lows seen in the previous quarter.

Cyclical
Conservative
Asset-Heavy

Outlook

The outlook remains cautious as the company navigates margin compression and lower capital efficiency (ROE at 4.4% in FY26). Performance is highly dependent on pricing power in the Polymer Inputs and Pharma Intermediates segments.

From the Annual Report (Key Quotes)

The Company operates only in one Business Segment i.e. 'Chemical' which constitutes single reportable segment.

Profit for the period (after tax) stood at ₹2,910.75 lakhs for the quarter ended June 30, 2026.

Official Quarterly Documents

Earnings Press Release
Official quarterly earnings release published by the company.
Download
Earnings Call Transcript
Management discussion and analyst Q&A.

Ask AI about this quarter

Sign in to ask AI questions grounded on the official earnings release and call transcript.

This summary is AI-generated from Excel Industries Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.

← Back to Excel Industries Limited AI analysis